3.2. CCFM1025 Intervention Enhanced the Sleep Quality of Insomnia Patients
sleep disturbance
In the CCFM1025-treated group, the participants’ PSQI score exhibited a notable drop in comparison to the initial baseline measurement (pre vs. post: F (1, 38) = 15.41, CCFM1025 also improved sleep quality by enhancing participants’ subjective sleep quality and reducing sleep disturbance (sleep quality score: pre vs. post: F (1, 38) =18.19, In the AIS table, AIS scores significantly decreased before and after CCFM1025 intervention, while there was no significant difference in the placebo group before and after intervention (pre-placebo vs. post-placebo: F (1, 38) = 13.46, 